Launches Let Hikma Cope With Competition On US Injectables

 
• By Aidan Fry

A stream of launches, including of vancomycin as its 100th injectable medicine in the US, is helping Hikma’s Injectables business segment to more than offset the effects of increased competition.

100
Hikma has now launched 100 injectable generics in the US • Source: Shutterstock

More from Products

More from Generics Bulletin